Elite Eyecare Medical Group a Medical Corporation
Elite Eyecare Medical Group a Medical Corporation was paid $2.83M by Medicaid between Jan 2018 and Nov 2024, across 22 billing codes. Its largest line is 67028, Intravitreal injection of a pharmacologic agent — 39% of everything it billed.
33Billing provider infoELITE EYECARE MEDICAL GROUP A MEDICAL CORPORATION
SANTA MARIA, CA 93454
SANTA MARIA, CA 93454
33aNPI1578521472assigned 05/02/2006
33bProvider typeOptometrist
28Total paid$2.83M
24GClaims56,766
24DCodes billed22
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Optometrist providers in California
Rank by total paid#15 of 1,899
Median peer was paid$23K
This provider vs. median126×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,403 | $292K | |
| 2019 | 8,376 | $348K | |
| 2020 | 7,072 | $306K | |
| 2021 | 8,191 | $358K | |
| 2022 | 9,514 | $526K | |
| 2023 | 9,514 | $510K | |
| 2024incomplete | 6,696 | $492K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 67028 | Intravitreal injection of a pharmacologic agent | 39% | 4,897 | 4,008 | $1.10M |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 12% | 910 | 750 | $335K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.3% | 7,959 | 7,556 | $206K |
| 92134 | 7.2% | 10,272 | 8,528 | $203K | |
| J9035 | Injection, bevacizumab, 10 mg | 5.6% | 2,082 | 1,689 | $158K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.2% | 2,746 | 2,685 | $118K |
| 67228 | 4.1% | 429 | 347 | $115K | |
| 92235 | 3.2% | 1,968 | 1,966 | $91K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 2.9% | 5,160 | 5,103 | $81K |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 2.7% | 142 | 115 | $75K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 2.6% | 4,152 | 4,026 | $73K |
| 92015 | Determination of refractive state | 2.4% | 7,794 | 7,749 | $69K |
10 more codes
| 92133 | 1.3% | 2,178 | $36K | |
| 92136 | 1.2% | 1,180 | $34K | |
| 92250 | 1.1% | 1,359 | $32K | |
| J7999 | Compounded drug, not otherwise classified | <1% | 1,456 | $24K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 213 | $20K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 454 | $16K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 162 | $13K |
| 92002 | <1% | 295 | $12K | |
| J0178 | Injection, aflibercept, 1 mg | <1% | 13 | $10K |
| 92083 | <1% | 945 | $10K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBYLSMA, STEPHEN (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Elite Eyecare Medical Group a Medical Corporation | Lompoc, CA | $302K |
| Elite Eyecare Medical Group a Medical Corporation | Santa Maria, CA | $28K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.